U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


TRV GP II, LLC (0001614073)
State location: MA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
THIRD ROCK VENTURES
29 NEWBURY STREET, 3RD FLOOR
BOSTON MA 02116
617-585-2000
Mailing Address
THIRD ROCK VENTURES
29 NEWBURY STREET, 3RD FLOOR
BOSTON MA 02116
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Revolution Medicines, Inc. 0001628171 2020-02-12 10 percent owner
Allena Pharmaceuticals, Inc. 0001624658 2017-11-01 10 percent owner
Jounce Therapeutics, Inc. 0001640455 2017-01-26 10 percent owner
MyoKardia Inc
Current Name:MyoKardia, Inc.
0001552451 2016-11-29 10 percent owner
Global Blood Therapeutics, Inc. 0001629137 2016-11-03 10 percent owner
Sage Therapeutics, Inc. 0001597553 2016-05-16 10 percent owner
Blueprint Medicines Corp 0001597264 2016-04-14 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016